I Received My Test Results…Now What?

I Received My YouScript Results, Now What? Here at YouScript we understand you may have questions about deciphering your results.  Pharmacogenetic analysis isn’t something that every doctor is currently familiar with, but if you’ve completed the test, you can consider yourself at the forefront of Precision Medicine (PM).  Receiving actionable results can help treat your illness, and/or know you’re taking … Read More

Oxycodone, Overdoses, and Pharmacogenetics

Everywhere we look, news about the epidemic of opiate abuse, both prescription and illicit, abounds. We hear about frightening statistics, celebrities and neighbors alike overdosing; even the availability of overdose reversal agents has become a talking point among presidential candidates.  Recently, the Centers for Disease Control and Prevention (CDC) reported here that 78 Americans die every day from an opioid … Read More

Many Patients Do Not Disclose Complementary/Alternative Treatments

An article published in JAMA Internal Medicine, April 2016 by Judy Jou, MA and Pamela Jo Johnson, MPH, PhD examined patterns of the use of complementary and alternative medicine (CAM), as well as rates of disclosure of CAM use to physicians. Data was collected through the 2012 National Health Interview Survey (NHIS) and CAM supplement to the Survey. Of the … Read More

Risk Stratification…What You Don’t Know Will Hurt You

The care management team is perhaps one of the largest sources of investment for ACOs or any other organization transitioning to a value-based payment model.  Therefore, it is critical that an organization use every piece of data available to guide the care team in identifying high-risk, high-cost patients to effectively manage the population as a whole. Only then does achieving … Read More

Population Health: YouScript’s Genetic Risk Analysis Tool

We’ve recently updated our Risk Analysis tool in YouScript to make it more useful for you! On the left side of the screen, you will see the Genetic Risk Stratification graph. This graph shows the likelihood of CYP pharmacogenetic testing being clinically actionable. It stratifies patients based on their genetic risk percentage into one of four categories: High Risk (≥40%) … Read More